Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability

<div>Solubility of efavirenz in different lipids [GMS: glyceryl monostearate, Comp: Compritol 888 ATO (glyceryl behenate), GTP: glyceryl tripalmitate (tripalmitin), GPS: glyceryl palmitostearate, GDS: glyceryl distearate, CP: cetyl palmitate].</div>

BioMed Research International

fig1

Figure 1

Figure 1: Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability 

Figure 1 | Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability 